(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMPAVIDO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMPAVIDO

ST13

US500000086758557

Class

5

Filing

86758557

Registration

4982102

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

06/23/2026

Trademark type

Word

Nice classes

5

Filing date

09/16/2015

Registration date

06/21/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/29/2026

Last transaction

06/23/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

LUXEMBOURG, LU

Examiner

BUCHANAN WILL, NORA

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

KNIGHT THERAPEUTICS EUROPE S.A.
KNIGHT THERAPEUTICS INTERNATIONAL S.A.
KNIGHT THERAPEUTICS (BARBADOS) INC.

Representatives

Jonathon T. Reavill Nixon & Vanderhye, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations used for the treatment of leishmaniasis

Publications

History of USPTO decisions and trademark events.

36 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/29/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/29/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/29/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/29/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

03/25/2026

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

03/25/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/25/2026

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

03/25/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/25/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/25/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/25/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/25/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/21/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/26/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/24/2022

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/24/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/26/2022

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

12/06/2021

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

10/23/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/23/2021

E815

TEAS SECTION 8 & 15 RECEIVED

07/15/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/21/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

06/21/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/05/2016

PUBO

PUBLISHED FOR OPPOSITION

04/05/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/16/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/02/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/02/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/01/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/01/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/11/2016

GNRT

NON-FINAL ACTION E-MAILED

01/11/2016

CNRT

NON-FINAL ACTION WRITTEN

01/11/2016

DOCK

ASSIGNED TO EXAMINER

01/03/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/21/2015

NWAP

NEW APPLICATION ENTERED

09/19/2015

Continuous trademark protection

Get notified about every new filing that threatens IMPAVIDO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.